These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 7410538)

  • 1. Chronobiological studies of plasma prolactin in women in Kyushu, Japan, and Minnesota, USA.
    Haus E; Lakatua DJ; Halberg F; Halberg E; Cornelissen G; Sackett LL; Berg HG; Kawasaki T; Ueno M; Uezono K; Matsuoka M; Omae T
    J Clin Endocrinol Metab; 1980 Sep; 51(3):632-40. PubMed ID: 7410538
    [No Abstract]   [Full Text] [Related]  

  • 2. Possible linkage between the ability to change the period (tau) of the prolactin and cortisol rhythms in women and breast cancer risk.
    Lewy H; Haus E; Ashkenazi IE
    Chronobiol Int; 2007; 24(2):365-81. PubMed ID: 17453854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circadian characteristics of urinary melatonin from clinically healthy young women at different civilization disease risks.
    Wetterberg L; Halberg F; Halberg E; Haus E; Kawasaki T; Ueno M; Uezono K; Cornelissen G; Matsuoka M; Omae T
    Acta Med Scand; 1986; 220(1):71-81. PubMed ID: 3766210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronobiologic pattern discrimination of plasma hormones, notably DHEA-S and TSH, classifies an expansive personality.
    Hermida RC; Halberg F; del Pozo F
    Chronobiologia; 1985; 12(2):105-36. PubMed ID: 3161711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolactin levels in populations at risk for breast cancer.
    Hill P; Wynder EL; Kumar H; Helman P; Rona G; Kuno K
    Cancer Res; 1976 Nov; 36(11 Pt 1):4102-6. PubMed ID: 975051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolactin and human breast cancer: a review.
    Nagasawa H
    Eur J Cancer (1965); 1979 Mar; 15(3):267-79. PubMed ID: 221222
    [No Abstract]   [Full Text] [Related]  

  • 7. Daughters of women with breast cancer have elevated mean 24-hour prolactin (PRL) levels and a partial resistance of PRL to dopamine suppression.
    Levin PA; Malarkey WB
    J Clin Endocrinol Metab; 1981 Jul; 53(1):179-83. PubMed ID: 7240375
    [No Abstract]   [Full Text] [Related]  

  • 8. Circadian variation of serum prolactin and TSH of women in health or with mammary carcinoma, fibroadenoma or fibrocystic mastopathy.
    Tarquini B; Gheri R; Romano S; Costa A; Cagnoni M; Lee JK; Halberg F
    Int J Chronobiol; 1980; 7(2):101-15. PubMed ID: 7450919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronobiology of serum iron concentration in subjects of different ages at different geographic locations.
    Nicolau GY; Haus E; Lakatua DJ; Bogdan C; Plîngă L; Irvine P; Popescu M; Petrescu E; Sackett-Lundeen L; Swoyer J
    Endocrinologie; 1987; 25(2):63-82. PubMed ID: 3629151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disordered nocturnal prolactin regulation in women with breast cancer.
    Malarkey WB; Schroeder LL; Stevens VC; James AG; Lanese RR
    Cancer Res; 1977 Dec; 37(12):4650-4. PubMed ID: 922745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormalities in evening plasma prolactin levels in nulliparous women with benign or malignant breast disease.
    Tarquini A; di Martino L; Malloci A; Kwa HG; van der Gugten AA; Bulbrook RD; Wang DY
    Int J Cancer; 1978 Dec; 22(6):687-90. PubMed ID: 721323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum prolactin concentrations throughout the menstrual cycle of normal women and patients with recent breast cancer.
    Cole EN; England PC; Sellwood RA; Griffiths K
    Eur J Cancer (1965); 1977 Jul; 13(7):677-84. PubMed ID: 598393
    [No Abstract]   [Full Text] [Related]  

  • 13. [Circadian and circumannual variations in the level of plasma TSH and prolactin in healthy adult males].
    Guagnano MT; Angelucci E; Del Ponte A; Boni R; Sensi S
    Boll Soc Ital Biol Sper; 1984 Nov; 60(11):2039-45. PubMed ID: 6525257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prolactin and human cancer of the breast. I. Levels of correlation].
    Cueto Ladrón de Guevara J; Villalba Moreno J; García Puche JL; Pedraza V
    Rev Esp Oncol; 1985; 32(3):439-58. PubMed ID: 3870536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolactin and breast cancer risk.
    Ingram DM; Nottage EM; Roberts AN
    Med J Aust; 1990 Oct; 153(8):469-73. PubMed ID: 2215338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronobiological study of pituitary adenomas and of the empty sella syndrome.
    Ferrari E; Bossolo PA; Baldi F; Daguati M; Fioravanti M; Facara S
    Chronobiologia; 1982; 9(2):241-8. PubMed ID: 7117046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mammary cancer risk: circulating TSH and prolactin, fibrocystic breast disease in chronoepidemiologic perspective.
    Tarquini B; Benvenuti M; Legnaioli M; Bazzani M; Cagnoni M; Halberg F
    Cancer Detect Prev; 1981; 4(1-4):525-34. PubMed ID: 7349819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum androgen levels and the menstrual cycle in women with benign or malignant breast disease.
    England PC; Sellwood RA; Knyba RE; Irvine JD
    Clin Oncol; 1981 Sep; 7(3):213-9. PubMed ID: 6211319
    [No Abstract]   [Full Text] [Related]  

  • 19. Proceedings: Prolactin in benign and malignant breast disease.
    Cole EN; England PC; Sellwood RA; Griffiths K
    J Endocrinol; 1976 Jun; 69(3):49P-50P. PubMed ID: 950543
    [No Abstract]   [Full Text] [Related]  

  • 20. [Plasma levels of prolactin in women with dysplasia and tumors of the breast (fibroadenoma and carcinoma of the breast)].
    Iturburu Belmonte IM; Basáñez Amuchastegui A; Jiménez Jiménez E; López de Tejada Cabeza I; Goicoechea García J; Méndez Martín J
    Rev Quir Esp; 1988; 15(1):17-21. PubMed ID: 3153353
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.